001 | 864473 | ||
005 | 20230215201828.0 | ||
024 | 7 | _ | |a 10.1080/02688697.2019.1639615 |2 doi |
024 | 7 | _ | |a 0268-8697 |2 ISSN |
024 | 7 | _ | |a 1360-046X |2 ISSN |
024 | 7 | _ | |a 2128/30696 |2 Handle |
024 | 7 | _ | |a 31407920 |2 pmid |
024 | 7 | _ | |a WOS:000480905300001 |2 WOS |
037 | _ | _ | |a FZJ-2019-04251 |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Schmitz, Ann Kristin |0 P:(DE-HGF)0 |b 0 |e Corresponding author |
245 | _ | _ | |a Diagnostic impact of additional O-(2-[18F]fluoroethyl)-L-tyrosine ( 18 F-FET) PET following immunotherapy with dendritic cell vaccination in glioblastoma patients |
260 | _ | _ | |a London [u.a.] |c 2021 |b Taylor & Francis |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1676461265_10240 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Objective: Vaccination therapy using tumour antigen-loaded, autologous dendritic cells (DC) is a promising therapeutic approach alongside standard treatment for glioblastoma (GBM). However, reliable diagnostic criteria regarding therapy monitoring are not established. Here, we analysed the impact of additional 18F-fluoroethyl-tyrosine positron emission tomography (18F-FET PET) imaging following DC vaccination therapy.Methods: We analysed data of GBM patients who received DC vaccination therapy. Following MRI diagnosis of tumour recurrence, additional static and dynamic 18F-FET PET imaging was performed. Vaccination was performed five times by intradermal injections, either weekly between concomitant radio/-chemotherapy and intermittent chemotherapy or after tumour recurrence, before re-radiation therapy. MRI and 18F-FET PET results were compared and correlated with clinical data.Results: Between 2003 and 2016, 5 patients were identified who received DC vaccination and 18F-FET PET imaging (1 female/4 males; mean age: 44 ± 14 y). 3/5 patients showed congruent results of tumour progression. In three patients 18F-FET PET indicated treatment related changes, which was in contrast to MRI findings that indicated tumour progression. In these patients 18F-FET PET results could be confirmed by either neuropathological diagnosis or according to the RANO criteriaConclusions: Despite the small patients number our results indicate an additional impact of 18F-FET PET for monitoring outcome following vaccination therapy. |
536 | _ | _ | |a 5252 - Brain Dysfunction and Plasticity (POF4-525) |0 G:(DE-HGF)POF4-5252 |c POF4-525 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef |
700 | 1 | _ | |a Sorg, Rüdiger V. |0 P:(DE-HGF)0 |b 1 |
700 | 1 | _ | |a Stoffels, Gabriele |0 P:(DE-Juel1)131627 |b 2 |u fzj |
700 | 1 | _ | |a Grauer, Oliver M. |0 P:(DE-HGF)0 |b 3 |
700 | 1 | _ | |a Galldiks, Norbert |0 P:(DE-Juel1)143792 |b 4 |u fzj |
700 | 1 | _ | |a Steiger, Hans-Jakob |0 P:(DE-HGF)0 |b 5 |
700 | 1 | _ | |a Kamp, Marcel A. |0 P:(DE-HGF)0 |b 6 |
700 | 1 | _ | |a Langen, Karl-Josef |0 P:(DE-Juel1)131777 |b 7 |u fzj |
700 | 1 | _ | |a Sabel, Michael |0 P:(DE-Juel1)165921 |b 8 |
700 | 1 | _ | |a Rapp, Marion |0 P:(DE-HGF)0 |b 9 |
773 | _ | _ | |a 10.1080/02688697.2019.1639615 |g p. 1 - 7 |0 PERI:(DE-600)1499131-7 |n 6 |p 736-742 |t British journal of neurosurgery |v 35 |y 2021 |x 1360-046X |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/864473/files/Schmitz%20Postprint%20BJN%202019.pdf |y Published on 2019-08-13. Available in OpenAccess from 2020-08-13. |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/864473/files/Schmitz%20Postprint%20BJN%202019.pdf?subformat=pdfa |x pdfa |y Published on 2019-08-13. Available in OpenAccess from 2020-08-13. |
909 | C | O | |o oai:juser.fz-juelich.de:864473 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 2 |6 P:(DE-Juel1)131627 |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 4 |6 P:(DE-Juel1)143792 |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 7 |6 P:(DE-Juel1)131777 |
913 | 1 | _ | |a DE-HGF |b Key Technologies |l Natural, Artificial and Cognitive Information Processing |1 G:(DE-HGF)POF4-520 |0 G:(DE-HGF)POF4-525 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-500 |4 G:(DE-HGF)POF |v Decoding Brain Organization and Dysfunction |9 G:(DE-HGF)POF4-5252 |x 0 |
914 | 1 | _ | |y 2022 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
915 | _ | _ | |a Embargoed OpenAccess |0 StatID:(DE-HGF)0530 |2 StatID |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b BRIT J NEUROSURG : 2017 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
920 | _ | _ | |l yes |
920 | 1 | _ | |0 I:(DE-Juel1)INM-3-20090406 |k INM-3 |l Kognitive Neurowissenschaften |x 0 |
920 | 1 | _ | |0 I:(DE-Juel1)INM-4-20090406 |k INM-4 |l Physik der Medizinischen Bildgebung |x 1 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-Juel1)INM-3-20090406 |
980 | _ | _ | |a I:(DE-Juel1)INM-4-20090406 |
980 | _ | _ | |a UNRESTRICTED |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|